Systolic Dysfunction Clinical Trial
Official title:
Improving Heart Failure Care in Minority Communities
For congestive heart failure (CHF) patients with systolic dysfunction, a randomized controlled trial compared nurse-based disease management to address problems in patient and clinician management with usual care for effects on hospitalization and functioning among ethnically-diverse patients in ambulatory practices.
Congestive heart failure (CHF) disproportionately afflicts Black and elderly people, and is
a leading cause of hospitalization > 65 years. Although effective therapies can improve
functioning and survival in patients with systolic dysfunction, many may not be receiving
the full benefit of existing knowledge, including counseling on self-management and
appropriate doses of medications. Patients play a critical role in managing a chronic
condition such as CHF, but may not have the skills to do so. Clinicians may not provide
counseling or medications consistent with evidence-based guidelines.
Systematic reviews of clinical-behavior change have suggested that interventions targeted to
specific problems are more likely to be successful. Based on shortfalls identified in
patient self-management and clinical care in Harlem, a predominately non-white area in
northern Manhattan, we tailored a nurse-management intervention to address the problems
documented, and evaluated its effectiveness in a randomized controlled trial. This trial
among primarily-minority patients addresses important gaps in this literature: the study
targeted problems documented among CHF patients in Harlem, enrolled patients from ambulatory
practices, randomly assigned patients between nurse-management and usual care, and evaluated
their subsequent health-related outcomes. Hypothesis: the nurse-management program would
result in nurse patients' having fewer hospitalizations and reporting better functioning.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
Terminated |
NCT00232388 -
Association of PICP Serum Marker in Patients With LVSD
|
Phase 1 | |
Completed |
NCT00689819 -
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
|
N/A | |
Completed |
NCT05175066 -
Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
|
Phase 3 | |
Recruiting |
NCT05519046 -
Cardiac Contractility Modulation in Chagas Heart Disease
|
N/A | |
Recruiting |
NCT04476576 -
Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy
|
N/A | |
Not yet recruiting |
NCT06428383 -
Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-043)
|
Phase 3 | |
Suspended |
NCT03755570 -
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
|
||
Not yet recruiting |
NCT03938090 -
Optimised MultiSite Pacing Vector Study
|
N/A | |
Recruiting |
NCT05408559 -
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
|
Phase 1/Phase 2 | |
Completed |
NCT01529463 -
Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients
|
N/A | |
Terminated |
NCT02450110 -
A Pilot Study of Spinal Cord Stimulation in Heart Failure Patients With Depressed Left Ventricular Function
|
N/A | |
Recruiting |
NCT05796050 -
Sex Related Differences in Cardiac Function
|
||
Completed |
NCT06129448 -
Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Type 1 Diabetes Mellitus
|
||
Completed |
NCT03349593 -
Prevalence of Hypovolemia and Heart Failure in Non-cardiac Surgery
|